Ginkgo Bioworks Holdings Inc expected to post a loss of $1.77 a share - Earnings Preview

Ginkgo Bioworks Holdings

02/05/2025 23:58

Ginkgo Bioworks Holdings Inc DNA.N, DNA is expected to show a rise in quarterly revenue when it reports  results on May 6 for the period ending March 31 2025

The Boston Massachusetts-based  company is expected to report a 2.0% increase in revenue to $38.696 million from $37.94 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Ginkgo Bioworks Holdings Inc is for a loss of $1.77 per share.

The current average analyst rating on the shares is "sell" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and 4 "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Ginkgo Bioworks Holdings Inc is $8.00​, above​ its last closing price of $7.04. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-1.49
-1.77
-2.00
Missed
-13
Sep. 30 2024
-2.87
-2.73
-0.94
Beat
65.5
Jun. 30 2024
-3.20
-3.12
-2.80
Beat
10.3​
Mar. 31 2024
-3.36
-3.33
-3.20
Beat
4
​​Dec. 31 2023
-4.17
-3.87
-4.40
Missed
-13.8
Sep. 30 2023
-3.34
-3.43
-6.40
Missed
-86.7​
Jun. 30 2023
-2.99
-3.37
-3.60
Missed
-6.8
Mar. 31 2023
-3.44
-3.60
-4.40
Missed
-22.2

This summary was machine generated May 2 at 22:58 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)